News

Photo of glowing, pink diamond-shaped figure. This is illuminated with light, encircled with a wreath of around 70 blue tube-like shapes.
Promethium’s secrets exposed
Male student wearing clear safety goggles peering through a 3D-printed item.
tnAchieves students learn about lab careers
Photo of a man in a black jacket suit with a blue shirt crossing his arms outside. He is smiling.
Wagner receives ASME Medal

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy

Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.  

2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg

Neutrons—Nanosize matters

A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.

ORNL Image

Neutrons peer into a running engine

Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source